đŹ Current Disease Focus:
Task Progress: 0%
đ„ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
đ§Ș Experimental Design
đŹ Clinical Trials
đ Treatment Development
This is a phase ll study of participants with untreated diffuse large B Cel...
Status
Recruiting
Location
Princess Margaret Cancer Centre
Start Date
2025-01-24
Trial ID
NCT06050694
Treatments Being Tested
The purpose of this research study is to see if investigators can predict h...
Status
Recruiting
Location
Wake Forest Baptist Comprehensive Cancer Center
Start Date
2022-09-02
Trial ID
NCT05212272
Newly diagnosed diffuse large B cell lymphoma (DLBCL) patients who enter th...
Status
Unknown
Location
The Catholic University of Korea Seoul St. Mary's Hospital
Start Date
2012-03-02
Trial ID
NCT01357733
Treatments Being Tested
The purpose of this study is to improve the outcome of elderly patients wit...
Status
Completed
Location
Saarland University Hospital
Start Date
2011-11
Trial ID
NCT01478542
About 60% of patients with DLBCL can be cured with a chemotherapy program. ...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2008-07-01
Trial ID
NCT00712582
To assess if percentage change in 18F-FLT PET/CT quantitative parameters (S...
Status
Completed
Location
UT Southwestern Medical Center
Start Date
2017-12-11
Trial ID
NCT03318497
The purpose of the study is to evaluate a new radiotracer called 64Cu-FBP8 ...
Status
Recruiting
Location
Massachusetts General Hospital
Start Date
2016-04-01
Trial ID
NCT03830320
Treatments Being Tested
Early interim-PET after two courses of chemotherapy is a powerful outcome p...
Status
Unknown
Location
Azienda Ospedaliera Santa Croce e Carle
Start Date
2006-01
Trial ID
NCT00877747
The specific aims of the study are: Primary: To determine the presence and...
Status
Recruiting
Location
Brigham MS Center, 60 Fenwood Road
Start Date
2016-05-02
Trial ID
NCT02649985
Treatments Being Tested
This study enrolls newly diagnosed unfavorable stage II /stage III-IV class...
Status
Completed
Location
Peking University People's Hospital
Start Date
2019-02-01
Trial ID
NCT07720011
Treatments Being Tested